Choi Jung Hyun, Park Jae Hyeong
Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
Department of Cardiology in Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
J Cardiovasc Imaging. 2021 Jan;29(1):20-30. doi: 10.4250/jcvi.2020.0128.
Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and it has become a pandemic problem. Cardiovascular diseases are common in COVID-19 patients, especially in severe forms of infection, and these are associated with higher mortality. SARS-CoV-2 infection can cause cardiovascular disease and worsen preexisting disease by direct invasion, hypoxia associated with pneumonia, and immunologic mechanisms. Because prompt detection and proper treatment can be critical to COVID-19 patients, echocardiographic examinations are essential diagnostic tools in the diagnosis and determination of treatment options. However, because there is an increased risk of infection during echocardiographic examinations, healthcare providers should pay attention to mitigate the risk of infection during the diagnosis and management of COVID-19 patients.
2019年新型冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,已成为一个全球性大流行问题。心血管疾病在COVID-19患者中很常见,尤其是在严重感染形式中,并且这些疾病与较高的死亡率相关。SARS-CoV-2感染可通过直接侵袭、与肺炎相关的缺氧以及免疫机制导致心血管疾病并使原有疾病恶化。由于及时检测和适当治疗对COVID-19患者至关重要,超声心动图检查是诊断和确定治疗方案的重要诊断工具。然而,由于超声心动图检查期间感染风险增加,医疗保健提供者在COVID-19患者的诊断和管理过程中应注意降低感染风险。